In a new step forward on the quest for better painkillers, scientists have developed a synthetic cannabinoid that keeps the ...

Poisonings linked to synthetic and semisynthetic cannabinoids (man-made products designed to mimic cannabis) are increasing ...

VIP36, a new CB1 agonist, targets a cryptic pocket to provide analgesia for chronic pain while minimizing side effects and ...

Cannabinoid-induced poisonings are leading to more hospital admissions as drug traffickers target puff bars, gummies, and ...

When it comes to cannabis compounds, THC and CBD get top billing, but they are just two of over 100 chemicals known as ...

A new study analyzes the disease burden and the risk factors for severity among people who suffer from a condition called cannabinoid hyperemesis syndrome. Researchers at the George Washington ...

Cresco Labs CRLBF reported fourth-quarter revenue of $175.91 million, surpassing estimates of $172.13 million but marking a ...

Researchers at Washington University and Stanford developed a cannabinoid compound that provides pain relief without ...

Regularly taking large amounts of cannabis might cause cannabinoid hyperemesis syndrome (CHS). CHS leads to severe nausea and vomiting that doesn't respond to typical anti-nausea drugs.

TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, ...